Repurposing anti-diabetic drugs for the treatment of Parkinson’s disease

The most pressing need in Parkinson’s disease (PD) clinical practice is to identify agents that might slow down, stop or reverse the neurodegenerative process of Parkinson’s disease and therefore avoid the onset of the most disabling, dopa-refractory symptoms of the disease. These include dementia, …

Source: Repurposing anti-diabetic drugs for the treatment of Parkinson’s disease: Rationale and clinical experience – PubMed

Ketogenic therapies for lymphedema

www.nature.com/articles/s42255-019-0090-3#:~:text=ketogenic%20diet%20or%20exogenous%20ketone%20bodies%20may%20alleviate%20lymphedema%20by%20increasing%20the%20formation%20of%20lymphatic%20vessels

elevation of lymph ketone body levels by a high-fat, low-carbohydrate ketogenic diet or by administration of the ketone body β-hydroxybutyrate increases lymphangiogenesis – www.nature.com/articles/s42255-019-0087-y

from the lab – vib.be/news/using-ketone-bodies-fight-against-lymphedema

 

 

10 Health Benefits of Low-Carb and Ketogenic Diets

Many studies show that low-carb and ketogenic diets can lead to dramatic weight loss and improve most major risk factors for heart disease and diabetes. Also, repeatedly shown (but not always) to help with or reverse PD and other neurologicsal conditions

 

Source: 10 Health Benefits of Low-Carb an

Parkinson’s disease and basal ganglia calcifications: prevalence and clinico-radiological correlations – PubMed

We reviewed computerized tomograms (CT) for basal ganglia and dentate nucleus calcifications in 79 patients with Parkinson’s disease (PD), 54 patients with Alzheimer’s disease (AD) and 109 controls aged 50 or more. When it was determined, no patient had disturbances in calcium metabolism. We found: …

Source: Parkinson’s disease and basal ganglia calcifications: prevalence and clinico-radiological correlations – PubMed